Selective COX-2 inhibitor (celecoxib) decreases cellular growth in prostate cancer cell lines independent of p53. - Katkoori, VR; Manne, K; Vital-Reyes, VS; Rodríguez-Burford, C; Shanmugam, C; Sthanam, M; Manne, U; Chatla, C; Abdulkadir, SA; Grizzle, WE (Biotechnic & Histochemistry, 2013)